INS and obesity due to melanocortin 4 receptor deficiency: The exception is the BPD, after which an improvement in both, hepatic and peripheral insulin sensitivity since early stages and to a greater extent compared to weight-matched controls undergoing other obesity interventions can be observed (19, 39).